Back to Results

Firefly Neuroscience Inc (AIFF)

Firefly Neuroscience, Inc. is a healthcare technology company focused on medical technology and artificial intelligence applications for brain health. Through its Brain Network Analytics software, the company supports diagnostic and treatment-related use cases in areas such as depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Its solutions are intended for use by pharmaceutical companies and medical practitioners. Firefly Neuroscience was founded in 2006 and is headquartered in Kenmore, New York. The company’s common stock trades on the NASDAQ under the symbol AIFF.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-AIFF
$1.29
10.8% Upside
Fair
—
—
—
Fair
—
—
—
0.0%
August 12, 2026
-1.9x
2.1x
11.4x
17.44 M
14.936 M
0.0%
87.8%
-28.8
—
84.1%
Valuation • Fair Value

Firefly Neuroscience Inc (NASDAQ-AIFF) Fair Value by Valuation Model

Compare the primary fair value estimate for Firefly Neuroscience Inc (NASDAQ-AIFF) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$1.29

Estimated upside of 10.8% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.38

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$1.19

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Firefly Neuroscience Inc (NASDAQ-AIFF) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Firefly Neuroscience Inc (NASDAQ-AIFF)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.584 M

Current operating scale indicator.

Revenue Forecast

1.998 M

Forward revenue estimate.

EBITDA

-8.383 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Firefly Neuroscience Inc (NASDAQ-AIFF) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Firefly Neuroscience Inc (NASDAQ-AIFF)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

7.14

Higher caution zone on this screen.

Altman Z-Score

-28.8

Lower score that deserves closer risk review.

FCF / Net Income

84.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Firefly Neuroscience Inc (NASDAQ-AIFF). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Firefly Neuroscience Inc (NASDAQ-AIFF)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 12, 2026

Days to Earnings

22

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Firefly Neuroscience Inc (NASDAQ-AIFF), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Firefly Neuroscience Inc (NASDAQ-AIFF) Stock Forecast & Technical Outlook

Review Firefly Neuroscience Inc (NASDAQ-AIFF) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Firefly Neuroscience Inc (NASDAQ-AIFF) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Firefly Neuroscience Inc (NASDAQ-AIFF) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Firefly Neuroscience Inc (NASDAQ-AIFF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Firefly Neuroscience Inc (NASDAQ-AIFF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Firefly Neuroscience Inc (NASDAQ-AIFF) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Firefly Neuroscience Inc (NASDAQ-AIFF)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Firefly Neuroscience Inc (NASDAQ-AIFF) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Firefly Neuroscience Inc (NASDAQ-AIFF) Stock FAQ

Quick answers about Firefly Neuroscience Inc (NASDAQ-AIFF) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$1.29
Estimated upside 10.8%
Valuation Rating
Undervalued
Estimated upside of 10.8%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Firefly Neuroscience Inc (NASDAQ-AIFF) is $1.29. This implies an estimated upside of 10.8% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 10.8% versus the current market price.

An analyst price target for Firefly Neuroscience Inc (NASDAQ-AIFF) is not currently available in the latest data file.

The current financial health read for Firefly Neuroscience Inc (NASDAQ-AIFF) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Firefly Neuroscience Inc (NASDAQ-AIFF) is August 12, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Firefly Neuroscience Inc (NASDAQ-AIFF) is -1.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Firefly Neuroscience Inc is 17.44 M.

The current enterprise value listed for Firefly Neuroscience Inc is 14.936 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Firefly Neuroscience Inc is NASDAQ-AIFF, and the stock is listed on NASDAQ.

Firefly Neuroscience Inc (NASDAQ-AIFF) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Firefly Neuroscience Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Firefly Neuroscience Inc is 87.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NASDAQ View more

Waystar Holding Corp (WAY) Waystar Holding Corp (WAY)
Heartflow Inc (HTFL) Heartflow Inc (HTFL)
Schrodinger Inc (SDGR) Schrodinger Inc (SDGR)
Certara Inc (CERT) Certara Inc (CERT)
Goodrx Holdings Inc (GDRX) Goodrx Holdings Inc (GDRX)
HealthStream Inc (HSTM) HealthStream Inc (HSTM)
Sophia Genetics SA (SOPH) Sophia Genetics SA (SOPH)
Trubridge Inc (TBRG) Trubridge Inc (TBRG)
Simulations Plus Inc (SLP) Simulations Plus Inc (SLP)
LifeMD Inc (LFMD) LifeMD Inc (LFMD)
LifeMD Inc Preferred Series A (LFMDP) LifeMD Inc Preferred Series A (LFMDP)
Health Catalyst Inc (HCAT) Health Catalyst Inc (HCAT)
OPTIMIZERx Corp (OPRX) OPTIMIZERx Corp (OPRX)
Definitive Healthcare Corp (DH) Definitive Healthcare Corp (DH)
CareCloud Inc (CCLD) CareCloud Inc (CCLD)
DarioHealth Corp (DRIO) DarioHealth Corp (DRIO)
Onemednet Corp (ONMD) Onemednet Corp (ONMD)
ITonic Holdings Ltd (ITOC) ITonic Holdings Ltd (ITOC)
Scienture Holdings Inc (SCNX) Scienture Holdings Inc (SCNX)
BullFrog AI Holdings Inc Unit (BFRG) BullFrog AI Holdings Inc Unit (BFRG)
Aclarion Inc (ACON) Aclarion Inc (ACON)
Vsee Health Inc (VSEE) Vsee Health Inc (VSEE)
Healthcare Triangle Inc (HCTI) Healthcare Triangle Inc (HCTI)
ISpecimen Inc (ISPC) ISpecimen Inc (ISPC)